Clinical trial
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00079391 |
|---|---|
| Title | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies |
| Official title | Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peri-transplant Cyclosporine on Chimerism |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematologic Malignancies, Bone Marrow Transplant Rejection |
| Intervention type | Device |
| Interventions | allogeneic hematopoietic stem cell transplantation |
| Enrollment | 50 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Sep 1, 2011 |
| First posted | Mar 10, 2004 |
| Last update posted | Oct 26, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: